Skip to main content
SpringerLink
Log in

Guidelines for the management of severe community-acquired pneumonia: one confusing recommendation. Author’s reply

  • Correspondence
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Nath S, Nachimuthu N, Sharma D (2023) Guidelines for the management of severe community-acquired pneumonia: one confusing recommendation. Intensive Care Med. https://doi.org/10.1007/s00134-023-07182-w

    Article  PubMed  Google Scholar 

  2. Martin-Loeches I, Torres A, Nagavci B, Aliberti S, Antonelli M, Bassetti M, Bos LD, Chalmers JD, Derde L, de Waele J, Garnacho-Montero J, Kollef M, Luna CM, Menendez R, Niederman MS, Ponomarev D, Restrepo MI, Rigau D, Schultz MJ, Weiss E, Welte T, Wunderink R (2023) ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia. Intensive Care Med 49:615–632

    Article  PubMed  Google Scholar 

  3. Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, Machado FR, McIntyre L, Ostermann M, Prescott HC, Schorr C, Simpson S, Wiersinga WJ, Alshamsi F, Angus DC, Arabi Y, Azevedo L, Beale R, Beilman G, Belley-Cote E, Burry L, Cecconi M, Centofanti J, Coz Yataco A, De Waele J, Dellinger RP, Doi K, Du B, Estenssoro E, Ferrer R, Gomersall C, Hodgson C, Møller MH, Iwashyna T, Jacob S, Kleinpell R, Klompas M, Koh Y, Kumar A, Kwizera A, Lobo S, Masur H, McGloughlin S, Mehta S, Mehta Y, Mer M, Nunnally M, Oczkowski S, Osborn T, Papathanassoglou E, Perner A, Puskarich M, Roberts J, Schweickert W, Seckel M, Sevransky J, Sprung CL, Welte T, Zimmerman J, Levy M (2021) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 47:1181–1247

    Article  PubMed  PubMed Central  Google Scholar 

  4. Martin-Loeches I, Garduno A, Povoa P, Nseir S (2022) Choosing antibiotic therapy for severe community-acquired pneumonia. Curr Opin Infect Dis 35:133–139

    Article  CAS  PubMed  Google Scholar 

  5. Meduri GU, Shih MC, Bridges L, Martin TJ, El-Solh A, Seam N, Davis-Karim A, Umberger R, Anzueto A, Sriram P, Lan C, Restrepo MI, Guardiola JJ, Buck T, Johnson DP, Suffredini A, Bell WA, Lin J, Zhao L, Uyeda L, Nielsen L, Huang GD (2022) Low-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia. Intensive Care Med 48:1009–1023

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Torres A, Chalmers JD, Dela Cruz CS, Dominedò C, Kollef M, Martin-Loeches I, Niederman M, Wunderink RG (2019) Challenges in severe community-acquired pneumonia: a point-of-view review. Intensive Care Med 45:159–171

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Intensive Care Medicine, Multidisciplinary Intensive Care Research Organization (MICRO), Dublin, D08 NYH1, Leinster, Ireland

    Ignacio Martin-Loeches

  2. Independent Researcher - Methodologist, I. Boletini 8-50000, Gjakovë, Kosovo

    Blin Nagavci

  3. Pulmonary Intensive Care Unit, Respiratory Institute, Hospital Clinic of Barcelona, IDIBAPS (Institut d’Investigacions Biomèdiques August Pi I Sunyer), University of Barcelona, CIBERes, 08380, Barcelona, Spain

    Antoni Torres

Authors
  1. Ignacio Martin-Loeches
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Blin Nagavci
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Antoni Torres
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ignacio Martin-Loeches.

Ethics declarations

Conflicts of interest

IML reports grants from GE, consulting fees from Gilead and MSD, lecture honoraria from MSD, Gilead and Mundipharma, and advisory board and lectures for Pfizer, MSD and Menarini, outside the submitted work. AT reports consulting fees and lecture honoraria from Pfizer, Poliphor, MSD, Jansen and OM Pharma, and advisory board and lectures for Pfizer, MSD, Atriva, Jansen and Menarini, outside the submitted work. BN served as the ERS guideline methodologist.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This comment refers to the article available online at https://doi.org/10.1007/s00134-023-07033-8.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Martin-Loeches, I., Nagavci, B. & Torres, A. Guidelines for the management of severe community-acquired pneumonia: one confusing recommendation. Author’s reply. Intensive Care Med 49, 1261–1262 (2023). https://doi.org/10.1007/s00134-023-07184-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-023-07184-8

Search

Navigation